184
Participants
Start Date
May 13, 2022
Primary Completion Date
October 12, 2024
Study Completion Date
October 12, 2024
Indomethacin suppository
Control Group: Patients will be randomized to receive a 100 mg indomethacin suppository will be administered immediately before the endoscopic procedure (20-30 minutes) and saline infusion will be given as needed.
Indomethacin suppository and high-flow lactated ringer infusion combination
Interventional group: Patients will be randomized to receive an indomethacin suppository that will be administered immediately before (20-30 minutes) the endoscopic procedure in combination with a lactated Ringer's infusion that will be administered with the following weight-based schedule: 3 cc/kg/h during ERCP, a bolus of 20 cc/kg after ERCP, and again 3 cc/kg/h for 8 hours after ERCP.
Ospedale Guglielmo da Saliceto - AUSL Piacenza, Piacenza
AUSL Bologna - Ospedale Maggiore Carlo Alberto Pizzardi, Bologna
Azienda USL di Modena - Ospedale di Carpi, Carpi
Azienda Ospedaliero-Universitaria di Modena - Ospedale civile di Baggiovara, Baggiovara
AUSL- IRCCS di Reggio Emilia, Reggio Emilia
Azienda Ospedaliero - Universitaria di Parma, Parma
Azienda Ospedaliero-Universitaria di Ferrara - Arcispedale sant'Anna, Ferrara
AUSL della Romagna - Ospedale Morgagni-Pierantoni di Forlì, Forlì
AUSL della Romagna - Ospedale Infermi di Rimini, Rimini
AUSL Romagna - Ospedale Santa Maria delle Croci, Ravenna
Azienda USL Reggio Emilia - IRCCS
OTHER_GOV